|
|
|
Insider
Information: |
Foley Todd |
Relationship: |
Director, 10% Owner |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
24,224,604 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$89,965,310 |
|
|
Total
Shares |
24,224,604 |
|
|
Total
Value |
$89,965,310 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-66.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celladon Corp |
CLDN |
Director |
2014-02-04 |
0 |
2014-02-04 |
1,066,775 |
Premium* |
|
Aratana Therapeutics, Inc. |
PETX |
10% Owner |
2014-03-07 |
0 |
2014-03-07 |
3,351,048 |
Premium* |
|
Chiasma, Inc |
CHMA |
Director, 10% Owner |
2015-07-21 |
0 |
2015-07-21 |
5,681,544 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
595,436 |
Premium* |
|
Radius Health Inc. |
RDUS |
Former 10% stockholder |
2016-09-27 |
0 |
2016-09-27 |
1,427,698 |
Premium* |
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
Director |
2017-10-10 |
0 |
2021-03-15 |
909,258 |
Premium* |
|
Harpoon Therapeutics, Inc. |
HARP |
10% Owner |
2019-02-12 |
0 |
2019-02-12 |
4,524,425 |
Premium* |
|
Repare Therapeutics Inc. |
RPTX |
Director |
2020-06-23 |
0 |
2021-07-12 |
2,242,636 |
Premium* |
|
Entrada Therapeutics, Inc. |
TRDA |
Director, 10% Owner |
2021-11-02 |
0 |
2021-11-02 |
4,425,784 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
86 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CLDN |
Celladon Corp |
Director |
|
2014-02-04 |
4 |
A |
$0.00 |
$90,960 |
I/I |
955,167 |
955,167 |
0 |
- |
|
CHMA |
Chiasma, Inc |
Director |
|
2015-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
5,681,544 |
5,681,544 |
0 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2015-10-20 |
4 |
A |
$0.00 |
$0 |
I/I |
595,436 |
595,436 |
0 |
- |
|
RDUS |
Radius Health Inc. |
Former 10% stockholder |
|
2016-09-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(713,849) |
1,427,698 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2017-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
2,567,014 |
2,596,392 |
0 |
- |
|
HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
|
2019-02-12 |
4 |
A |
$0.00 |
$0 |
I/I |
3,521,767 |
3,843,830 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2020-06-23 |
4 |
A |
$0.00 |
$0 |
I/I |
2,753,772 |
2,753,772 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2021-03-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(24,271) |
2,603,089 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2021-05-18 |
4 |
AS |
$0.00 |
$0 |
I/I |
(21,834) |
2,570,943 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Director |
|
2021-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
4,325,784 |
4,325,784 |
0 |
- |
|
HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
|
2019-02-12 |
4 |
OE |
$0.05 |
$21,260 |
I/I |
432,119 |
4,275,949 |
0 |
- |
|
CLDN |
Celladon Corp |
Director |
|
2014-02-04 |
4 |
B |
$8.00 |
$892,864 |
I/I |
111,608 |
1,066,775 |
2.1 |
- |
|
HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
|
2019-02-12 |
4 |
S |
$14.00 |
$21,336 |
I/I |
(1,524) |
4,274,425 |
0 |
- |
|
HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
|
2019-02-12 |
4 |
B |
$14.00 |
$3,500,000 |
I/I |
250,000 |
4,524,425 |
1.5 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-03-20 |
4 |
AS |
$15.00 |
$16,500 |
I/I |
(1,100) |
2,361,763 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-03-26 |
4 |
AS |
$15.04 |
$34,592 |
I/I |
(2,300) |
2,359,463 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-03-19 |
4 |
AS |
$15.07 |
$123,574 |
I/I |
(8,200) |
2,362,863 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-04-01 |
4 |
AS |
$15.10 |
$233,476 |
I/I |
(15,462) |
2,324,893 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-03-17 |
4 |
AS |
$15.12 |
$145,953 |
I/I |
(9,653) |
2,383,844 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-03-18 |
4 |
AS |
$15.14 |
$193,504 |
I/I |
(12,781) |
2,371,063 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-03-31 |
4 |
AS |
$15.16 |
$289,677 |
I/I |
(19,108) |
2,340,355 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2017-10-10 |
4 |
B |
$17.00 |
$1,700,000 |
I/I |
100,000 |
2,696,392 |
2.25 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
10% Owner |
|
2014-03-07 |
4 |
S |
$19.95 |
$250,153 |
I/I |
(12,539) |
0 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-06 |
4 |
AS |
$20.00 |
$32,520 |
I/I |
(1,626) |
2,287,044 |
0 |
% |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-18 |
4 |
AS |
$20.00 |
$426,980 |
I/I |
(21,349) |
2,210,528 |
0 |
% |
|
86 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|